Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference42 articles.
1. Reichert, J. M. Trends in development and approval times for new therapeutics in the United States. Nat. Rev. Drug Discov. 2, 695–702 (2003).
2. Preziosi, P. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? Nat. Rev. Drug Discov. 3, 521–526 (2004).
3. FDA, U.S. Department of Health and Human Services. Challenge and opportunity on the critical path to new medical products. Rockville, MD: U.S. FDA (2004).
4. Piccini, J. P. et al. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the critical path initiative. Am. Heart J. 158, 317–326 (2009).
5. Fermini, B. et al. A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm. J. Biomol. Screen. 21, 1–11 (2015).
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献